Outcome of a nationwide screening programme in young individuals

Abstract Funding Acknowledgements Type of funding sources: Other. Main funding source(s): Cardiac Risk in the Young. Background Sudden cardiac death (SCD) seemingly affects young, healthy individuals and is therefore recognised as an important public health concern for athletes and non-athletes. However, systematic population screening is not recommended in the United Kingdom (UK). Concerns include the low reported incidence of SCD in young individuals, the efficacy of the electrocardiogram (ECG) and the lack of robust evidence on cardiac screening. We sought to determine the diagnostic yield of a nationwide cardiac screening programme in young individuals. Importantly, we sought to report on the frequency of false-negative screen-test results, which is underrecognized in the literature, and the incidence of sudden cardiac arrest (SCA) and SCD amongst individuals who underwent screening. Methods From 2007 through 2018, 104,369 consecutive individuals, aged 14 to 35 years, underwent voluntary cardiac screening (62% were male, 91% were non-athletes). Initial evaluation consisted of a health questionnaire (HQ), ECG, and clinical consultation. Selective on-site echocardiography was available at the discretion of the consulting physician. Clinical outcomes were sourced from the Office for National Statistics-Hospital-Episode-Statistics database and an online HQ. Results During screening 280 (0.27%) individuals were found to have a cardiac condition associated with SCA/SCD and 115 received potentially life-saving treatments. A further 166 (0.16%) with congenital or valvular abnormalities were identified. During a mean follow-up of 6.2 ± 2.5 years, an additional 86 individuals, considered to have normal screening, were found to have a cardiac condition associated with SCA/SCD.After screening there were 86 deaths. Cardiac disorders accounted for 20 deaths (23%), all of which were sudden. In addition, 15 individuals survived a SCA. Primary electrical disorders accounted for 21 (60%) of the 35 cases of SCA/SCD, followed by cardiomyopathies (n=6), and congenital or acquired coronary artery disease (n=5). On the basis of a total of 626,550 person-years (PY), the combined incidence of SCA/SCD was 1:17,901 PY (5.6 per 100,000 PY). Males were at 3.5-fold higher risk than females (1:12,488 PY vs 1:44,067 PY, p < 0.01). For prevention of SCA/SCD the programme’s sensitivity was 19.4% with a specificity of 97.5%. For identifying conditions associated with SCD, the programme’s sensitivity was 76.5% with a specificity was 97.8%. Conclusion Diseases that are associated with SCD were identified in 0.27% of young individuals who underwent cardiac screening. A further 86 (0.08%) conditions were identified after screening. The incidence of SCA and SCD was 5.6 per 100,000 person-years, which is considerable higher than previous estimates in the general population. Most of these events were due to confirmed or presumed primary electrical disorders that had not been detected on screening.